211 related articles for article (PubMed ID: 11985331)
1. Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?
Filip M; Papla I
Pol J Pharmacol; 2001; 53(6):577-85. PubMed ID: 11985331
[TBL] [Abstract][Full Text] [Related]
2. Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
Filip M; Wydra K; Inan SY; Dziedzicka-Wasylewska M; Przegaliński E
Eur J Pharmacol; 2004 Sep; 498(1-3):143-51. PubMed ID: 15363988
[TBL] [Abstract][Full Text] [Related]
3. Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats.
Filip M; Nowak E; Papla I; Przegaliński E
J Physiol Pharmacol; 2001 Jun; 52(2):249-63. PubMed ID: 11453104
[TBL] [Abstract][Full Text] [Related]
4. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
[TBL] [Abstract][Full Text] [Related]
5. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
Millan MJ; Dekeyne A
Int J Neuropsychopharmacol; 2007 Oct; 10(5):579-93. PubMed ID: 17076935
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
Dekeyne A; Gobert A; Iob L; Cistarelli L; Melon C; Millan MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):213-8. PubMed ID: 11702096
[TBL] [Abstract][Full Text] [Related]
8. Dopamine β-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats.
Manvich DF; DePoy LM; Weinshenker D
J Pharmacol Exp Ther; 2013 Dec; 347(3):564-73. PubMed ID: 24068832
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of tianeptine.
Alici T; Kayir H; Aygoren MO; Saglam E; Uzbay IT
Psychopharmacology (Berl); 2006 Jan; 183(4):446-51. PubMed ID: 16292591
[TBL] [Abstract][Full Text] [Related]
11. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
Filip M; Przegaliński E
Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
[TBL] [Abstract][Full Text] [Related]
12. Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats.
Mantsch JR; Wisniewski S; Vranjkovic O; Peters C; Becker A; Valentine A; Li SJ; Baker DA; Yang Z
Pharmacol Biochem Behav; 2010 Dec; 97(2):310-6. PubMed ID: 20816889
[TBL] [Abstract][Full Text] [Related]
13. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
[TBL] [Abstract][Full Text] [Related]
14. Effects of dopamine D(2)-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition.
Collins GT; Jackson JA; Koek W; France CP
Eur J Pharmacol; 2014 Apr; 729():123-31. PubMed ID: 24561049
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus properties of antidepressant agents: a review.
Dekeyne A; Millan MJ
Behav Pharmacol; 2003 Sep; 14(5-6):391-407. PubMed ID: 14501253
[TBL] [Abstract][Full Text] [Related]
16. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
Lagos P; Scorza C; Monti JM; Jantos H; Reyes-Parada M; Silveira R; Ponzoni A
Eur Neuropsychopharmacol; 1998 May; 8(2):113-20. PubMed ID: 9619689
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys.
Sinnott RS; Mach RH; Nader MA
Drug Alcohol Depend; 1999 Apr; 54(2):97-110. PubMed ID: 10217549
[TBL] [Abstract][Full Text] [Related]
18. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
Garner KJ; Baker LE
Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
[TBL] [Abstract][Full Text] [Related]
19. The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys.
Achat-Mendes C; Platt DM; Newman AH; Spealman RD
Psychopharmacology (Berl); 2009 Sep; 206(1):73-84. PubMed ID: 19513698
[TBL] [Abstract][Full Text] [Related]
20. Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats.
Filip M; Papla I; Nowak E; Jungersmith K; Przegaliński E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):226-34. PubMed ID: 12172705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
